These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

339 related articles for article (PubMed ID: 8644985)

  • 1. Somatostatin receptor scintigraphy: its sensitivity compared with that of other imaging methods in detecting primary and metastatic gastrinomas. A prospective study.
    Gibril F; Reynolds JC; Doppman JL; Chen CC; Venzon DJ; Termanini B; Weber HC; Stewart CA; Jensen RT
    Ann Intern Med; 1996 Jul; 125(1):26-34. PubMed ID: 8644985
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Somatostatin receptor scintigraphy in gastrinomas.
    Jensen RT; Gibril F
    Ital J Gastroenterol Hepatol; 1999 Oct; 31 Suppl 2():S179-85. PubMed ID: 10604126
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Somatostatin receptor scintigraphy in forty-eight patients with the Zollinger-Ellison syndrome. GRESZE: Groupe d'Etude du Syndrome de Zollinger-Ellison.
    de Kerviler E; Cadiot G; Lebtahi R; Faraggi M; Le Guludec D; Mignon M
    Eur J Nucl Med; 1994 Nov; 21(11):1191-7. PubMed ID: 7859770
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prospective study of somatostatin receptor scintigraphy and its effect on operative outcome in patients with Zollinger-Ellison syndrome.
    Alexander HR; Fraker DL; Norton JA; Bartlett DL; Tio L; Benjamin SB; Doppman JL; Goebel SU; Serrano J; Gibril F; Jensen RT
    Ann Surg; 1998 Aug; 228(2):228-38. PubMed ID: 9712569
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Distinguishing small hepatic hemangiomas from vascular liver metastases in gastrinoma: use of a somatostatin-receptor scintigraphic agent.
    Termanini B; Gibril F; Doppman JL; Reynolds JC; Stewart CA; Sutliff VE; Venzon DJ; Jensen RT
    Radiology; 1997 Jan; 202(1):151-8. PubMed ID: 8988205
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Value of somatostatin receptor scintigraphy: a prospective study in gastrinoma of its effect on clinical management.
    Termanini B; Gibril F; Reynolds JC; Doppman JL; Chen CC; Stewart CA; Sutliff VE; Jensen RT
    Gastroenterology; 1997 Feb; 112(2):335-47. PubMed ID: 9024287
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Specificity of somatostatin receptor scintigraphy: a prospective study and effects of false-positive localizations on management in patients with gastrinomas.
    Gibril F; Reynolds JC; Chen CC; Yu F; Goebel SU; Serrano J; Doppman JL; Jensen RT
    J Nucl Med; 1999 Apr; 40(4):539-53. PubMed ID: 10210211
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Detection of bone metastases in patients with endocrine gastroenteropancreatic tumors: bone scintigraphy compared with somatostatin receptor scintigraphy.
    Lebtahi R; Cadiot G; Delahaye N; Genin R; Daou D; Peker MC; Chosidow D; Faraggi M; Mignon M; Le Guludec D
    J Nucl Med; 1999 Oct; 40(10):1602-8. PubMed ID: 10520698
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bone metastases in patients with gastrinomas: a prospective study of bone scanning, somatostatin receptor scanning, and magnetic resonance image in their detection, frequency, location, and effect of their detection on management.
    Gibril F; Doppman JL; Reynolds JC; Chen CC; Sutliff VE; Yu F; Serrano J; Venzon DJ; Jensen RT
    J Clin Oncol; 1998 Mar; 16(3):1040-53. PubMed ID: 9508189
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Localization of neuroendocrine tumours with [111In] DTPA-octreotide scintigraphy (Octreoscan): a comparative study with CT and MR imaging.
    Shi W; Johnston CF; Buchanan KD; Ferguson WR; Laird JD; Crothers JG; McIlrath EM
    QJM; 1998 Apr; 91(4):295-301. PubMed ID: 9666953
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparative analysis of diagnostic techniques for localization of gastrointestinal neuroendocrine tumors.
    Gibril F; Jensen RT
    Yale J Biol Med; 1997; 70(5-6):509-22. PubMed ID: 9825478
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Primary cardiac gastrinoma causing Zollinger-Ellison syndrome.
    Gibril F; Curtis LT; Termanini B; Fritsch MK; Lubensky IA; Doppman JL; Jensen RT
    Gastroenterology; 1997 Feb; 112(2):567-74. PubMed ID: 9024311
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Scintigraphy with 111In-octreotide in a case of primary hepatic gastrinoma].
    Bello Arques P; Hervás Benito I; Mateo Navarro A
    Rev Esp Med Nucl; 2001 Aug; 20(5):381-5. PubMed ID: 11470073
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prospective study of the ability of computed axial tomography to localize gastrinomas in patients with Zollinger-Ellison syndrome.
    Wank SA; Doppman JL; Miller DL; Collen MJ; Maton PN; Vinayek R; Slaff JI; Norton JA; Gardner JD; Jensen RT
    Gastroenterology; 1987 Apr; 92(4):905-12. PubMed ID: 3556996
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Somatostatin receptor localization of pancreatic endocrine tumors.
    Corleto VD; Scopinaro F; Angeletti S; Materia A; Basso N; Polettini E; Annibale B; Schillaci O; D'Ambra G; Marignani M; Gualdi G; Bordi C; Passaro EJ; Delle Fave G
    World J Surg; 1996 Feb; 20(2):241-4. PubMed ID: 8661825
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Somatostatin receptor scintigraphy in preoperative diagnosis of the site of endocrine gastrointestinal tumors].
    Weinel RJ; Kisker O; Joseph K; Welcke U; Zaraca F; Rothmund M
    Chirurg; 1994 Oct; 65(10):849-55. PubMed ID: 7821043
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Preoperative detection of duodenal gastrinomas and peripancreatic lymph nodes by somatostatin receptor scintigraphy. Groupe D'etude Du Syndrome De Zollinger-Ellison.
    Cadiot G; Lebtahi R; Sarda L; Bonnaud G; Marmuse JP; Vissuzaine C; Ruszniewski P; Le Guludec D; Mignon M
    Gastroenterology; 1996 Oct; 111(4):845-54. PubMed ID: 8831579
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cost-effectiveness analysis of somatostatin receptor scintigraphy.
    Kwekkeboom DJ; Lamberts SW; Habbema JD; Krenning EP
    J Nucl Med; 1996 Jun; 37(6):886-92. PubMed ID: 8683305
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prospective comparative study of ability of MR imaging and other imaging modalities to localize tumors in patients with Zollinger-Ellison syndrome.
    Pisegna JR; Doppman JL; Norton JA; Metz DC; Jensen RT
    Dig Dis Sci; 1993 Jul; 38(7):1318-28. PubMed ID: 8325191
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Definition of the role of somatostatin receptor scintigraphy in gastrointestinal neuroendocrine tumor localization.
    Jensen RT; Gibril F; Termanini B
    Yale J Biol Med; 1997; 70(5-6):481-500. PubMed ID: 9825476
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.